Patient card
Patient card
Search by company, common medicine name, or title of Risk Minimisation Material
The patient card is intended to further raise awareness of patients and/ or caregivers and healthcare professionals on the risk of bleeding during treatment with apixaban and its appropriate management.
Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.
This risk minimisation material is for Apixaban Krka tablets for all indications. Please ensure that you are familiar with this material before prescribing Apixaban Krka as it contains important safety information on the potential risk of bleeding during treatment with Apixaban and provides guidance on how to manage that risk. If you would like to obtain hard copies of the Apixaban Krka 2.5mg & 5mg Prescriber Guide and/or Patient Alert Card and/or SPCs, please contact Krka UK Limited (Email: [email protected], phone: +44 (0) 207 164 6156). Risk minimisation materials can only be delivered to UK registered healthcare premises.
This Patient Alert Card provides information to healthcare professionals on the anticoagulant therapy and contains important contact information in the event of emergencies.
Patients should be advised to carry the Patient Alert Card with them at all times and to show it to every healthcare professional.
Apixaban 2.5mg film-coated tablets patient alert card
Apixaban 5mg film-coated tablets patient alert card
Patients prescribed Apixaban (Zydus UK) will receive a Patient Card in the medication pack with the package leaflet. Please ensure you have read and understood the information in the card because it contains important safety information including the importance of taking Apixaban (Zydus UK) regularly as instructed by your treating Doctor, the main signs and symptoms of bleeding, and when to seek medical attention. Please carry the Patient Card with you at all times and show it to every healthcare professional including pharmacists. If you would like to obtain hard copies of the Apixaban (Zydus UK) Patient Alert Card, please contact us via our Medical Information (Telephone: 0800 995 6034; Email: [email protected]) with your specific request. This is UK Only Risk minimisation materials.
Patients prescribed with Apixaban 2.5 mg and 5 mg film-coated tablets from Marketing Authorisation Holder, Silicon Pharma Limited will receive a Patient Alert Card in the medication pack along with the package leaflet. Please ensure you have read and understood the information in the card because it contains important safety information including the importance of taking Apixaban tablets regularly as instructed by your treating Doctor, the main signs and symptoms of bleeding, and when to seek medical attention. Please carry the Patient Alert Card with you at all times and show it to every healthcare professional including pharmacists. Patient Alert Card is approved by MHRA in 11/2025. This is for UK Only additional risk minimisation materials.
This additional risk minimisation material is for Apixaban 2.5 mg and 5 mg film coated tablet from Marketing Authorisation Holder, Silicon Pharma Limited. Please ensure that you are familiar with this material before prescribing Apixaban Tablets as it contains important safety information on the potential risk of bleeding during treatment and provides guidance on how to manage that risk. Prescriber Guide is approved by MHRA in 11/2025. This is for UK Only additional risk minimisation material.
Are you a healthcare professional?